4/A

OWNERSHIP DOCUMENT

Company: NRX Pharmaceuticals, Inc.
Filed: November 23, 2022
Period of Report: October 21, 2022
Accession Number: 0000950142-22-003250

View Document ↗ View on SEC.gov ↗